by Team Small News | May 8, 2025 | Biocon, Pharma
The fiscal fourth quarter earnings season is currently underway, with numerous large, mid, and small cap companies having already released their Q4 results. Major IT companies such as Tata Consultancy Services, Infosys, Wipro, and HCL Tech, as well as other prominent... by Team Small News | May 1, 2025 | Biocon, Pharma
The biotech industry is booming, and numerous top companies are seeking talented professionals to join their teams. With 18 years of experience serving bio professionals and the biotech industry, Biotecnika is a trusted platform that provides updates on job... by Team Small News | Apr 29, 2025 | Biocon, Pharma
Kiran Mazumdar-Shaw, the Executive Chairperson of Biocon Limited, has expressed her disappointment and concern over the current state of Bengaluru, once known as the “Garden City”. She tweeted a video showcasing the poor condition of Lal Bagh, a prominent... by Team Small News | Apr 15, 2025 | Biocon, Pharma
Biocon Biologics, a biopharmaceutical company, has reached a settlement and license agreement with Regeneron to commercialize its aflibercept-jbvf (Yesafili) biosimilar, an interchangeable version of Regeneron’s aflibercept, in the United States. The agreement... by Team Small News | Apr 12, 2025 | Biocon, Pharma
Siddharth Mittal, CEO of Biocon Limited, has questioned the feasibility of shifting pharmaceutical manufacturing back to the US due to higher costs. At the Carnegie Global Technology Summit, he pointed out that Indian companies cannot afford to bring back... by Team Small News | Apr 11, 2025 | Biocon, Pharma
Siddharth Mittal, CEO and Managing Director of Biocon Limited, expressed concerns about the feasibility of shifting pharmaceutical manufacturing from India and China to the US, due to the significant cost difference. He stated that if a drug is manufactured in China,...